Showing results (101-110 of 297) with videos related to

Sort By:
Pageof 30
Annals of Diagnostic Pathology|March 16, 2020
Histology of the normal ovary in premenopausal patientsElvio G Silva, Grace Kim, Rania Bakkar, et al.
Blood Cancer Journal|October 21, 2025
Prognostic impact of early NGS MRD dynamics and cytomolecular risk in newly diagnosed B-cell ALLNicholas J Short, Elias Jabbour, Walid Macaron, et al.
Archives of Pathology & Laboratory Medicine|December 7, 2023
T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic FeaturesSiba El Hussein, Hong Fang, Fatima Zahra Jelloul, et al.
European Journal of Haematology|January 1, 2017
Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCHBeenu Thakral, L Jeffrey Medeiros, Parth Desai, et al.
Genes|March 28, 2025
Cryptic KMT2A::AFDN Fusion Due to AFDN Insertion into KMT2A in a Patient with Acute Monoblastic LeukemiaQing Wei, Gokce A Toruner, Beenu Thakral, et al.
The Journal of Infectious Diseases|January 10, 2014
Intrauterine growth restriction caused by underlying congenital cytomegalovirus infectionLenore Pereira, Matthew Petitt, Alex Fong, et al.
American Journal of Clinical Pathology|October 22, 2015
Clinical validation of a multipurpose assay for detection and genotyping of CALR mutations in myeloproliferative neoplasmsMeenakshi Mehrotra, Rajyalakshmi Luthra, Rajesh R Singh, et al.
American Journal of Clinical Pathology|April 29, 2016
Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic FeaturesSanam Loghavi, Carlos E Bueso-Ramos, Rashmi Kanagal-Shamanna, et al.
Leukemia|March 13, 2022
Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patientsMahsa Khanlari, C Cameron Yin, Koichi Takahashi, et al.
Nature Communications|November 13, 2024
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trialJuan Jose Rodriguez-Sevilla, Vera Adema, Kelly S Chien, et al.
Pageof 30